Global Bipolar Disorders Treatment Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Bipolar Disorders Treatment Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Drug Class (Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Bipolar Disorders Treatment Market was valued at USD 9,351.2 million in 2023 and is expected to reach USD 15,017.3 million by 2031 while growing at a CAGR of 6.1% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global bipolar disorders treatment market growth. Treatment for bipolar disorder usually encompasses a blend of medication, psychotherapy, lifestyle changes, and occasionally hospitalization for severe cases, aiming to stabilize mood fluctuations, minimize episode frequency and intensity, and enhance overall quality of life.
The escalating prevalence of Bipolar Disorder, coupled with continuous research and development endeavors, fuels the discovery of new drugs and treatment modalities, such as innovative mood stabilizers, antipsychotics, and adjunctive therapies, thereby propelling the bipolar disorder treatment market. Nevertheless, the market's growth is impeded by the high cost of treatment and the adverse effects of medications.
Furthermore, the global bipolar disorders treatment industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Drug Class Analysis
The Global Bipolar Disorders Treatment Market is segmented among Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others, based on Drug Class. In 2023, Antipsychotics accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Distribution Channel Analysis
The Global Bipolar Disorders Treatment Market is segmented among Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, based on Distribution Channel. In 2023, Hospital Pharmacies accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Bipolar Disorders Treatment Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are AbbVie Inc., Allergan PLC, AstraZeneca Plc, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals Inc., Novartis AG, Otsuka Holdings Co. Ltd, and Pfizer Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Bipolar Disorders Treatment Market Dynamics
Drivers
Restraints
Opportunity
4. Global Bipolar Disorders Treatment Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Bipolar Disorders Treatment Market Segmentation, By Drug Class
Global Bipolar Disorders Treatment Market Share Analysis, By Drug Class
Global Bipolar Disorders Treatment Market Growth Analysis, By Drug Class
Global Bipolar Disorders Treatment Market Trends, By Drug Class
o Antipsychotics
o Antidepressants
o Mood Stabilizers
o Anti-anxiety Drugs and Others
6. Global Bipolar Disorders Treatment Market Segmentation, By Distribution Channel
Global Bipolar Disorders Treatment Market Share Analysis, By Distribution Channel
Global Bipolar Disorders Treatment Market Growth Analysis, By Distribution Channel
Global Bipolar Disorders Treatment Market Trends, By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
7. Global Bipolar Disorders Treatment Market Segmentation, By Region
Global Bipolar Disorders Treatment Market Share Analysis, By Region
Global Bipolar Disorders Treatment Market Growth Analysis, By Region
Global Bipolar Disorders Treatment Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
AbbVie Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Allergan PLC
AstraZeneca Plc
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals Inc.
Novartis AG
Otsuka Holdings Co. Ltd
Pfizer Inc.
*Similar analysis will be provided for each company listed above.